Otsuka Pharmaceutical Co., Ltd. et al v. Teva Pharmaceuticals USA, Inc. > Summary
Court Case Number 1:19-cv-01955
Filing Date Oct 15, 2019
Termination Date Apr 27, 2022
Court Delaware District Court
Status Dismissed - Other
JudgesLeonard P. Stark
Defendant
Plaintiff Attorneys
21Otsuka Pharmaceutical
Attorney Name: Steven J. Balick
Ashby & Geddes
Otsuka Pharmaceutical
Attorney Name: Andrew C. Mayo
Ashby & Geddes
H. Lundbeck A/S
Attorney Name: Steven J. Balick
Ashby & Geddes
H. Lundbeck A/S
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Otsuka Pharmaceutical
Attorney Name: Douglas Cheek
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Eric J. Fues
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: Douglas Cheek
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: Eric J. Fues
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: James B. Monroe
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Denise Main
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Tyler B. Latcham
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Collette Corser
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: Collette Corser
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: Tyler B. Latcham
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: Denise Main
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: James B. Monroe
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Erin McGeehan Sommers
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: Erin McGeehan Sommers
Finnegan, Henderson, Farabow, Garrett & Dunner
Attorney Name: Douglas Cheek
Attorney Name: Erin McGeehan Sommers
Attorney Name: Collette Corser
Defendant Attorneys
8Teva Pharmaceuticals
Attorney Name: Karen E. Keller
Shaw Keller LLP
Teva Pharmaceuticals
Attorney Name: Naomi L. Birbach
Goodwin Procter LLP
Teva Pharmaceuticals
Attorney Name: Elizabeth J. Holland
Goodwin Procter LLP
Teva Pharmaceuticals
Attorney Name: Emily L. Rapalino
Goodwin Procter LLP
Teva Pharmaceuticals
Attorney Name: Srikanth K. Reddy
Goodwin Procter LLP
Teva Pharmaceuticals
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
Teva Pharmaceuticals
Attorney Name: Elizabeth J. Holland
A&O Shearman
Teva Pharmaceuticals
Attorney Name: James P. Breen
Goodwin Procter LLP
Counter Defendant
4H. Lundbeck A/S
Attorney Name: Steven J. Balick
Ashby & Geddes
H. Lundbeck A/S
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Otsuka Pharmaceutical
Attorney Name: Steven J. Balick
Ashby & Geddes
Otsuka Pharmaceutical
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Counter Claimant
2Teva Pharmaceuticals
Attorney Name: Karen E. Keller
Shaw Keller LLP
Teva Pharmaceuticals
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
Cause
35:271 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
10307419 | Tablet comprising 7-[4-(4-benzo[b]thiopen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof | Jun 4, 2019 |
09839637 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Dec 12, 2017 |
08618109 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Dec 31, 2013 |
08349840 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Jan 8, 2013 |
07888362 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Feb 15, 2011 |